Fonte: Frontiers in Nutrition. Unidades: EEFERP, FMRP
Assuntos: HIPOTÁLAMO, INFLAMAÇÃO, JEJUM, OBESIDADE
ABNT
OLIVEIRA, Luciana da Costa et al. Using intermittent fasting as a non-pharmacological strategy to alleviate obesity-induced hypothalamic molecular pathway disruption. Frontiers in Nutrition, v. 9, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.3389/fnut.2022.858320. Acesso em: 01 set. 2024.APA
Oliveira, L. da C., Morais, G. P., Ropelle, E. R., Moura, L. P. de, Cintra, D. E., Pauli, J. R., et al. (2022). Using intermittent fasting as a non-pharmacological strategy to alleviate obesity-induced hypothalamic molecular pathway disruption. Frontiers in Nutrition, 9, 1-15. doi:10.3389/fnut.2022.858320NLM
Oliveira L da C, Morais GP, Ropelle ER, Moura LP de, Cintra DE, Pauli JR, Freitas EC de, Rorato R, Silva ASR da. Using intermittent fasting as a non-pharmacological strategy to alleviate obesity-induced hypothalamic molecular pathway disruption [Internet]. Frontiers in Nutrition. 2022 ; 9 1-15.[citado 2024 set. 01 ] Available from: https://doi.org/10.3389/fnut.2022.858320Vancouver
Oliveira L da C, Morais GP, Ropelle ER, Moura LP de, Cintra DE, Pauli JR, Freitas EC de, Rorato R, Silva ASR da. Using intermittent fasting as a non-pharmacological strategy to alleviate obesity-induced hypothalamic molecular pathway disruption [Internet]. Frontiers in Nutrition. 2022 ; 9 1-15.[citado 2024 set. 01 ] Available from: https://doi.org/10.3389/fnut.2022.858320